Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Preemptive antiviral therapy with entecavir can reduce acute deterioration of hepatic function following transarterial chemoembolization

Sun Hong Yoo, Jeong Won Jang, Jung Hyun Kwon, Seung Min Jung, Bohyun Jang, Jong Young Choi

Clin Mol Hepatol. 2016;22(4):458-465. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0054

View: 10241 Download: 137 Web of Science: 11 Crossref: 12

Comparison of hepatic MDCT, MRI, and DSA to explant pathology for the detection and treatment planning of hepatocellular carcinoma

Lauren M. Ladd, Temel Tirkes, Mark Tann, David M. Agarwal, Matthew S. Johnson, Bilal Tahir, Kumaresan Sandrasegaran

Clin Mol Hepatol. 2016;22(4):450-457. Published online December 14, 2016

DOI: https://doi.org/10.3350/cmh.2016.0036

View: 10187 Download: 162 Web of Science: 7 Crossref: 6

Glypican-3 level assessed by the enzyme-linked immunosorbent assay is inferior to alpha-fetoprotein level for hepatocellular carcinoma diagnosis

Yejoo Jeon, Eun Sun Jang, Yun Suk Choi, Jin-Wook Kim, Sook-Hyang Jeong

Clin Mol Hepatol. 2016;22(3):359-365. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0033

View: 13581 Download: 157 Web of Science: 24 Crossref: 22

Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B

Jaemin Lee, Sun Hong Yoo, Won Sohn, Hyung Woo Kim, Yong Sun Choi, Jung Ho Won, Jin Young Heo, Sang Jong Park, Young Min Park

Clin Mol Hepatol. 2016;22(3):339-349. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0021

View: 12990 Download: 170 Web of Science: 20 Crossref: 23

Editorial

Does obesity increase the risk of hepatocellular carcinoma in chronic hepatitis B patients?

Byoung Kuk Jang

Clin Mol Hepatol. 2016;22(3):336-338. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0104

View: 9190 Download: 123 Web of Science: 2 Crossref: 1

Review

The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy

Ioannis Varbobitis, George V. Papatheodoridis

Clin Mol Hepatol. 2016;22(3):319-326. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0045

View: 14843 Download: 414 Web of Science: 76 Crossref: 77

Original Article

Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma

Jun Young Kim, Dong Hyun Sinn, Geum-Youn Gwak, Gyu-Seong Choi, Aldosri Meshal Saleh, Jae-Won Joh, Sung Ki Cho, Sung Wook Shin, Keumhee Chough Carriere, Joong Hyun Ahn, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik

Clin Mol Hepatol. 2016;22(2):250-258. Published online June 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0015

View: 12797 Download: 203 Web of Science: 43 Crossref: 44

Review

Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma

Massimo Roncalli, Amedeo Sciarra, Luca Di Tommaso

Clin Mol Hepatol. 2016;22(2):199-211. Published online May 18, 2016

DOI: https://doi.org/10.3350/cmh.2016.0101

View: 20654 Download: 630 Web of Science: 41 Crossref: 39

Liver Imaging

Intraductal malignant tumors in the liver mimicking cholangiocarcinoma: Imaging features for differential diagnosis

Ah Yeong Kim, Woo Kyoung Jeong

Clin Mol Hepatol. 2016;22(1):192-197. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.192

View: 12798 Download: 243 Web of Science: 12 Crossref: 14

Original Article

Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis

Jung Min Lee, Byoung Kuk Jang, Yoo Jin Lee, Wang Yong Choi, Sei Myong Choi, Woo Jin Chung, Jae Seok Hwang, Koo Jeong Kang, Young Hwan Kim, Anil Kumar Chauhan, Soo Young Park, Won Young Tak, Young Oh Kweon, Byung Seok Kim, Chang Hyeong Lee

Clin Mol Hepatol. 2016;22(1):160-167. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.160

View: 12710 Download: 203 Web of Science: 85 Crossref: 74

Review

A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016

Su Jong Yu

Clin Mol Hepatol. 2016;22(1):7-17. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.7

View: 21619 Download: 557 Web of Science: 231 Crossref: 216

Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future

Hyun Young Woo, Jeong Heo

Clin Mol Hepatol. 2015;21(4):344-348. Published online December 24, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.4.344

View: 9600 Download: 208 Web of Science: 30 Crossref: 28

Original Article

Long-term outcomes of patients with advanced hepatocellular carcinoma who achieved complete remission after sorafenib therapy

Jung Gil Park

Clin Mol Hepatol. 2015;21(3):287-294. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.287

View: 9700 Download: 79 Web of Science: 28 Crossref: 29

Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease

Chansik An, Youn Ah Choi, Dongil Choi, Yong Han Paik, Sang Hoon Ahn, Myeong-Jin Kim, Seung Woon Paik, Kwang-Hyub Han, Mi-Suk Park

Clin Mol Hepatol. 2015;21(3):279-286. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.279

View: 14693 Download: 159 Web of Science: 65 Crossref: 66

Influence of P53 on the radiotherapy response of hepatocellular carcinoma

Ana R. Gomes, Ana M. Abrantes, Ana F. Brito, Mafalda Laranjo, João E. Casalta-Lopes, Ana C. Gonçalves, Ana B. Sarmento-Ribeiro, Maria F. Botelho, José G. Tralhão

Clin Mol Hepatol. 2015;21(3):257-267. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.257

View: 12781 Download: 126 Web of Science: 31 Crossref: 28

Editorial

P53 expression in hepatocellular carcinoma: influence on the radiotherapeutic response of the hepatocellular carcinoma

Yu Rim Lee, Soo Young Park

Clin Mol Hepatol. 2015;21(3):230-231. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.230

View: 7633 Download: 75 Web of Science: 12 Crossref: 11

Review

The mutational landscape of hepatocellular carcinoma

Ju-Seog Lee

Clin Mol Hepatol. 2015;21(3):220-229. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.220

View: 15899 Download: 400 Web of Science: 99 Crossref: 91

Personalized management of cirrhosis by non-invasive tests of liver fibrosis

Grace Lai-Hung Wong, Wendell Zaragoza Espinosa, Vicnent Wai-Sun Wong

Clin Mol Hepatol. 2015;21(3):200-211. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.200

View: 10842 Download: 130 Web of Science: 24 Crossref: 26

Original Article

The usefulness of contrast-enhanced ultrasonography in the early detection of hepatocellular carcinoma viability after transarterial chemoembolization: pilot study

Youn Zoo Cho, So Yeon Park, Eun Hee Choi, Soon Koo Baik, Sang Ok Kwon, Young Ju Kim, Seung Hwan Cha, Moon Young Kim

Clin Mol Hepatol. 2015;21(2):165-174. Published online June 26, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.2.165

View: 10294 Download: 98 Web of Science: 20 Crossref: 18

Predictive factors of contrast-enhanced ultrasonography for the response to transarterial chemoembolization in hepatocellular carcinoma

Kil Hyo Park, Soon Ha Kwon, Yong Sub Lee, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Sang Gyune Kim, Sang-Woo Cha, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim, Yong Jae Kim

Clin Mol Hepatol. 2015;21(2):158-164. Published online June 26, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.2.158

View: 9033 Download: 120 Web of Science: 10 Crossref: 7

Review

New perspectives on the management of hepatocellular carcinoma with portal vein thrombosis

Hyun Young Woo, Jeong Heo

Clin Mol Hepatol. 2015;21(2):115-121. Published online June 26, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.2.115

View: 11560 Download: 160 Web of Science: 42 Crossref: 31

Hepatitis C virus-induced hepatocellular carcinoma

Nicolas Goossens, Yujin Hoshida

Clin Mol Hepatol. 2015;21(2):105-114. Published online June 26, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.2.105

View: 20929 Download: 354 Web of Science: 126 Crossref: 121

Liver Imaging

Recent advances in the imaging of hepatocellular carcinoma

Myung-Won You, So Yeon Kim, Kyoung Won Kim, So Jung Lee, Yong Moon Shin, Jin Hee Kim, Moon-Gyu Lee

Clin Mol Hepatol. 2015;21(1):95-103. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.95

View: 11622 Download: 127 Web of Science: 8 Crossref: 8

Case Report

Low-dose steroid-induced tumor lysis syndrome in a hepatocellular carcinoma patient

Jin Ok Kim, Dae Won Jun, Hye Jin Tae, Kang Nyeong Lee, Hang Lak Lee, Oh Young Lee, Ho Soon Choi, Byung Chul Yoon, Joon Soo Hahm

Clin Mol Hepatol. 2015;21(1):85-88. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.85

View: 9616 Download: 113 Web of Science: 13 Crossref: 12

Original Article

Alteration of laboratory findings after radiofrequency ablation of hepatocellular carcinoma: relationship to severity of the underlying liver disease and the ablation volume

Sang-Wook Shin, Woo Kyoung Jeong, Sanghyeok Lim, Yongsoo Kim, Jinoo Kim

Clin Mol Hepatol. 2015;21(1):71-79. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.71

View: 8515 Download: 113 Web of Science: 3 Crossref: 4

Fibroblast growth factor receptor isotype expression and its association with overall survival in patients with hepatocellular carcinoma

Hyo Jeong Lee, Hyo Jeong Kang, Kang Mo Kim, Eun Sil Yu, Ki Hun Kim, Seung-Mi Kim, Tae Won Kim, Ju Hyun Shim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee

Clin Mol Hepatol. 2015;21(1):60-70. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.60

View: 9622 Download: 133 Web of Science: 21 Crossref: 21

Combined treatment with silibinin and either sorafenib or gefitinib enhances their growth-inhibiting effects in hepatocellular carcinoma cells

Ha Ra Gu, Su Cheol Park, Su Jin Choi, Jae Cheol Lee, You Cheoul Kim, Chul Ju Han, Jin Kim, Ki Young Yang, Yeon Joo Kim, Geum Youb Noh, So Hyeon No, Jae-Hoon Jeong

Clin Mol Hepatol. 2015;21(1):49-59. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.49

View: 13676 Download: 129 Web of Science: 34 Crossref: 30

Liver Pathology

Sarcomatoid hepatocellular carcinoma with mixed osteoclast-like giant cells and chondroid differentiation

Kyoung-Bun Lee

Clin Mol Hepatol. 2014;20(3):313-316. Published online September 26, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.3.313

View: 8085 Download: 76 Web of Science: 12 Crossref: 14

Case Report

A synchronous hepatocellular carcinoma and renal cell carcinoma treated with radio-frequency ablation

Yoon Serk Lee, Jeong Han Kim, Hyeon Young Yoon, Won Hyeok Choe, So Young Kwon, Chang Hong Lee

Clin Mol Hepatol. 2014;20(3):306-309. Published online September 25, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.3.306

View: 7283 Download: 50 Web of Science: 6 Crossref: 5

Gastrectomy for the treatment of refractory gastric ulceration after radioembolization with ⁹⁰Y microspheres

Sun Young Yim, Jin Dong Kim, Jin Yong Jung, Chang Ha Kim, Yeon Seok Seo, Hyung Joon Yim, Soon Ho Um, Ho Sang Ryu, Yun Hwan Kim, Chong Suk Kim, Eun Shin

Clin Mol Hepatol. 2014;20(3):300-305. Published online September 25, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.3.300

View: 9141 Download: 66 Web of Science: 9 Crossref: 11

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next

Viewed By 12260	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 7276	Radiogenomics of intrahepatic cholangiocarcinoma predicts immunochemotherapy response and identifies therapeutic target
Viewed By 6942	MAFLD: How is it different from NAFLD?
Viewed By 5587	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 5375	Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment

Cited By 366	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 348	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 232	MAFLD: How is it different from NAFLD?
Cited By 122	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 116	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search